期刊文献+

凉血化瘀中药治疗特发性脉络膜新生血管临床观察 被引量:2

Therapeutic effect of liangxuehuayu decoction for the treatment of idiopathic choroidal neovascularization
在线阅读 下载PDF
导出
摘要 目的:通过临床病例,观察凉血化瘀中药治疗特发性脉络膜新生血管(idiopathic choroidal neovascularization,ICNV)的疗效。方法:对46例46眼确诊的ICNV病变患者服凉血化瘀中药治疗,服中药3mo,总观察时间9mo。观察比较治疗前后最佳矫正视力(best corrected visual acuity,BCVA)、荧光眼底血管造影(fundus fluorescein angiography,FFA)和光学相干断层扫描(optic coherent tomography,OCT)图像。结果:末次随访时,中药治疗46眼中,视力平均提高0.21,较治疗前有统计意义;FFA检查发现:显效(CNV闭合)34眼(73.9%),有效(CNV部分闭合)7眼(15.2%),进步(CNV小部分闭合)4眼(8.7%),无效(CNV扩大)0眼,较治疗前显著改善。OCT检查发现:CNV型别由治疗前活动期38眼(82.6%)、中间期8眼(17.4%),转变为有效(瘢痕期)38眼(82.6%),进步(中间期)6眼(13.1%),无效(活动期)2眼(4.4%),具有统计学意义。结论:中药凉血化瘀可以促进ICNV中CNV闭合。 AIM:To investigate the therapeutic effect of liang-xuehuayu decoction for the treatment of idiopathic choroidal neovascularization(ICNV).·METHODS:The clinical data of 46 patients(46 eyes) with ICNV who had been followed up for 9 months after therapy of Chinese medicine for CNV were analyzed.The changes of the best corrected visual acuity(BCVA),fundus fluorescein angiography(FFA) and optic coherent tomography(OCT) were observed and analyzed.·RESULTS:At the end of the follow-up period,the BCVA improved 0.21,the vision improved obviously(≥2 lines) in 25 eyes(54.3%),kept stable(changed within 1line) in 16 eyes(34.8%),and decreased(≥2 lines) in 5 eyes(10.9%).The results of FFA showed completely closed CNV in 34 eyes(73.9%),partly closed CNV in 7 eyes(15.2%),unclosed CNV in 4 eyes(8.7%) and enlarged CNV in 0 eye.OCT showed scar stage in 38 eyes(82.6%),middle stage in 6 eyes(13.1%) and active stage in 2 eyes(4.4%).·CONCLUSION:Chinese medicine of liangxuehuayu is an effective treatment for most patients with CNV caused by ICNV and can promote the closure of CNV.
出处 《国际眼科杂志》 CAS 2009年第11期2195-2197,共3页 International Eye Science
关键词 中药 脉络膜新生血管 特发性脉络膜新生血管 凉血化瘀 traditional Chinese medicine choroidal neovascularization idiopathic choroidal neovasculariza-tion liangxuehuayu
作者简介 李学晶,女,博士,主治医师,研究方向:眼底病的中医药防治及机理研究。通讯作者:李学晶.zw71@yahoo.com.cn
  • 相关文献

参考文献16

二级参考文献72

共引文献181

同被引文献46

  • 1王雨生,严密.黄斑变性患者的希望——评2006年度十大科学进展之一[J].中华眼底病杂志,2007,23(1):1-3. 被引量:16
  • 2张承芬.眼底病学[M].北京:人民卫生出版社,1997.166.
  • 3全国眼底病研究协作组.老年性黄斑变性临床诊断标准.眼科新进展,1986,6(4):15-15.
  • 4Ambati J, Ambati BK, Y 00 SH, et al. Age - related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003 ;48 :257 -293.
  • 5Owen C. Chemokine receptors in airway disease: which receptors to target? Pulm Pharmacol Ther 2001 ; 14: 193-202.
  • 6Pease JE, Williams TJ. Chemokines and their receptors in allergic disease. J Allergy Clin Immunol 2006; 118 :305-318.
  • 7Willems 11, Ijzennan AP. Small molecule antagonists for chemokine CCR3 receptors. Med Res Rev 2010;30:778-817.
  • 8Salcedo R, Young HA, Ponce ML, et al . Eotaxin (CCLll) induces in vivo angiogenic responses by human CCR3 + endothelial cells. J Immunol2001 ; 166: 7571-7578.
  • 9Takeda A, Baffi JZ, Kleinman ME, et al. CCR3 is a target for age?related macular degeneration diagnosis and therapy. Nature 2009; 460 : 225-230.
  • 10王慧娟,唐由之.凉血化瘀方治疗湿性老年黄斑变性临床研究[J].中国中医眼科杂志,2008,18(6):322-324. 被引量:13

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部